Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs ALKEM LABORATORIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA ALKEM LABORATORIES AJANTA PHARMA/
ALKEM LABORATORIES
 
P/E (TTM) x 23.7 33.4 70.9% View Chart
P/BV x 4.9 4.3 112.9% View Chart
Dividend Yield % 0.8 1.1 70.2%  

Financials

 AJANTA PHARMA   ALKEM LABORATORIES
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-22
ALKEM LABORATORIES
Mar-22
AJANTA PHARMA/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,6144,068 39.7%   
Low Rs1,0892,671 40.8%   
Sales per share (Unadj.) Rs391.1889.4 44.0%  
Earnings per share (Unadj.) Rs83.4140.5 59.4%  
Cash flow per share (Unadj.) Rs98.1166.0 59.1%  
Dividends per share (Unadj.) Rs9.5034.00 27.9%  
Avg Dividend yield %0.71.0 69.7%  
Book value per share (Unadj.) Rs382.1722.4 52.9%  
Shares outstanding (eoy) m85.42119.57 71.4%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.53.8 91.2%   
Avg P/E ratio x16.224.0 67.6%  
P/CF ratio (eoy) x13.820.3 67.8%  
Price / Book Value ratio x3.54.7 75.8%  
Dividend payout %11.424.2 47.1%   
Avg Mkt Cap Rs m115,433402,868 28.7%   
No. of employees `000NANA-   
Total wages/salary Rs m6,45819,627 32.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m33,410106,342 31.4%  
Other income Rs m1,1571,627 71.1%   
Total revenues Rs m34,567107,968 32.0%   
Gross profit Rs m9,29320,380 45.6%  
Depreciation Rs m1,2533,040 41.2%   
Interest Rs m102524 19.5%   
Profit before tax Rs m9,09518,443 49.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,9681,640 120.0%   
Profit after tax Rs m7,12716,803 42.4%  
Gross profit margin %27.819.2 145.1%  
Effective tax rate %21.68.9 243.4%   
Net profit margin %21.315.8 135.0%  
BALANCE SHEET DATA
Current assets Rs m24,54884,354 29.1%   
Current liabilities Rs m8,37748,053 17.4%   
Net working cap to sales %48.434.1 141.8%  
Current ratio x2.91.8 166.9%  
Inventory Days Days4242 99.7%  
Debtors Days Days1165 17.2%  
Net fixed assets Rs m19,25943,245 44.5%   
Share capital Rs m172239 71.8%   
"Free" reserves Rs m32,46986,134 37.7%   
Net worth Rs m32,64086,373 37.8%   
Long term debt Rs m1694 17.5%   
Total assets Rs m43,807127,599 34.3%  
Interest coverage x90.236.2 249.0%   
Debt to equity ratio x00 46.3%  
Sales to assets ratio x0.80.8 91.5%   
Return on assets %16.513.6 121.5%  
Return on equity %21.819.5 112.2%  
Return on capital %28.221.9 128.4%  
Exports to sales %018.7 0.0%   
Imports to sales %00-   
Exports (fob) Rs mNA19,924 0.0%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m18,67819,924 93.7%   
Fx outflow Rs m3,6623,911 93.7%   
Net fx Rs m15,01616,013 93.8%   
CASH FLOW
From Operations Rs m5,62011,110 50.6%  
From Investments Rs m-741-14,351 5.2%  
From Financial Activity Rs m-4,6003,796 -121.2%  
Net Cashflow Rs m279580 48.1%  

Share Holding

Indian Promoters % 70.5 57.2 123.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 21.4 20.2 105.8%  
FIIs % 8.2 4.5 184.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 29.5 42.8 68.9%  
Shareholders   62,048 79,721 77.8%  
Pledged promoter(s) holding % 17.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    ZYDUS LIFESCIENCES    


More on AJANTA PHARMA vs ALKEM LABORATORIES

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs ALKEM LABORATORIES Share Price Performance

Period AJANTA PHARMA ALKEM LABORATORIES S&P BSE HEALTHCARE
1-Day 0.69% 0.07% -0.45%
1-Month -7.39% -5.52% -2.33%
1-Year -11.76% -9.78% -5.95%
3-Year CAGR 23.59% 15.47% 20.82%
5-Year CAGR 6.95% 9.21% 11.40%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the ALKEM LABORATORIES share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 70.5% stake in the company. In case of ALKEM LABORATORIES the stake stands at 57.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of ALKEM LABORATORIES.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 9.5 per share. This amounted to a Dividend Payout ratio of 11.4%.

ALKEM LABORATORIES paid Rs 34.0, and its dividend payout ratio stood at 24.2%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of ALKEM LABORATORIES.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Tanks 320 Points| PolicyBazaar Stake Sale| Oil & Gas and Auto Stocks Witness Most Selling(10:30 am)

Indian share markets opened on a negative note today halting their eight-day rally, amid a weak trend in global markets.